MEA Urinary Tract Infection (UTI) Drugs Market: Antibiotics and Cystitis Leading the Charge
The MEA Urinary Tract Infection (UTI) Drugs Market is experiencing significant and steady growth, with specific drug class and clinical indication segments acting as primary catalysts. The market, valued at USD 0.28 Billion in 2024, is projected to reach USD 0.4 Billion by 2035, driven by the critical roles of these segments in addressing the most common forms of urinary tract...
0 Commentarii 0 Distribuiri 4 Views 0 previzualizare